@peterbachmd Fair pt that study is wo attribution tho interested in your thoughts on #immunotherapy in #lungcancer. Would seem fair to suggest that it has had impact & may contribute to these results. Costs could be better but this is in line for benef
RT @sitcancer: #JITC Research Article: The impact of PD-L1 on survival and value of the immune check point inhibitors in non-small-cell lun…
RT @sitcancer: #JITC Research Article: The impact of PD-L1 on survival and value of the immune check point inhibitors in non-small-cell lun…
RT @sitcancer: #JITC Research Article: The impact of PD-L1 on survival and value of the immune check point inhibitors in non-small-cell lun…